Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection
The Laryngoscope, 11/02/09
Oplatek A et al. – Clinicopathological variables including AJCC tumor stage, tumor site, presence of N+ disease, and lymphovascular invasion may be used as prognostic factors in predicting survival and recurrence after a definitive resection of ACC of the head and neck.
Related Articles
Role of radiotherapy in adenoid cystic carcinoma of the head and neck
The Journal of Laryngology & Otology, 10/06/09
Relevance Score: 67%
Prognostic value of quantitative p63 immunostaining in adenoid cystic carcinoma of salivary gland assessed by computerized image analysis
Cancer, 11/04/09
Relevance Score: 66%
Mixed epithelial and stromal tumour of the kidney: imaging features
BJU International, 10/14/09
Relevance Score: 65%
Encapsulated apocrine papillary carcinoma of the breast—a tumour of uncertain malignant potential: report of five cases
Virchows Archiv, 11/02/09
Relevance Score: 64%
Concurrent Renal Cell Carcinoma and Central Nervous System Lymphoma in a Patient with Autosomal Dominant Polycystic Kidney Disease
Medical Principles and Practice, 10/06/09
Relevance Score: 63%
Today in Head and Neck...keeping you current
Receive free subspecialty "5-minute updates" via email
N2 Disease in Patients With Head and Neck Squamous Cell Cancer Treated With Chemoradiotherapy
Archives of Otolaryngology, 11/25/09
Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer
Archives of Otolaryngology, 11/25/09
Laser-induced thermal therapy and cisplatin for recurrent head and neck cancer: A case characterized by an unusually long disease-free survival
ENT Journal, 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


